ES556467A0 - Un procedimiento para la preparacion de derivados de furanona. - Google Patents
Un procedimiento para la preparacion de derivados de furanona.Info
- Publication number
- ES556467A0 ES556467A0 ES556467A ES556467A ES556467A0 ES 556467 A0 ES556467 A0 ES 556467A0 ES 556467 A ES556467 A ES 556467A ES 556467 A ES556467 A ES 556467A ES 556467 A0 ES556467 A0 ES 556467A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- preparation
- furanone derivatives
- furanone
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75080185A | 1985-07-01 | 1985-07-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8707946A1 ES8707946A1 (es) | 1987-09-01 |
ES556467A0 true ES556467A0 (es) | 1987-09-01 |
Family
ID=25019225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES556467A Expired ES8707946A1 (es) | 1985-07-01 | 1986-06-23 | Un procedimiento para la preparacion de derivados de furanona. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0209274A3 (es) |
JP (1) | JPS625976A (es) |
KR (1) | KR870000908B1 (es) |
CN (1) | CN86104450A (es) |
AU (1) | AU583930B2 (es) |
DK (1) | DK301886A (es) |
ES (1) | ES8707946A1 (es) |
HU (1) | HUT44530A (es) |
IL (1) | IL79212A0 (es) |
NZ (1) | NZ216647A (es) |
PH (1) | PH22938A (es) |
PT (1) | PT82850B (es) |
ZA (1) | ZA864674B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4952605A (en) * | 1983-08-03 | 1990-08-28 | The Regents Of The University Of California | Manoalide analogs |
US4789749A (en) * | 1984-06-18 | 1988-12-06 | The Regents Of The University Of California | Manoalide analogs |
US5081147A (en) * | 1990-03-15 | 1992-01-14 | Allergan, Inc. | 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents |
US5043457A (en) * | 1990-04-17 | 1991-08-27 | Allergan, Inc. | 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents |
US5089485A (en) * | 1988-11-18 | 1992-02-18 | Allergan, Inc. | Anti-inflammatory furanones |
US5134128A (en) * | 1987-06-08 | 1992-07-28 | Allergan, Inc. | Anti-inflammatory furanones |
US5037811A (en) * | 1990-04-17 | 1991-08-06 | Allergan, Inc. | 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5H)-furanones as anti-inflammatory agents |
US5059611A (en) * | 1988-11-18 | 1991-10-22 | Allergan, Inc. | Anti-inflammatory 5-hydroxy-2-furanones |
CA1329390C (en) * | 1987-06-08 | 1994-05-10 | John N. Bonfiglio | Anti-inflammatory furanones |
US5171863A (en) * | 1987-06-08 | 1992-12-15 | Allergan, Inc. | Intermediates for preparing 4-substituted 2-5(H)-furanones as anti-inflammatory agents |
US5026725A (en) * | 1988-06-06 | 1991-06-25 | American Home Products Corporation | Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones |
US4916241A (en) * | 1988-06-06 | 1990-04-10 | American Home Products Corporation | Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones |
US4957917A (en) * | 1989-10-25 | 1990-09-18 | Allergan, Inc. | Anti-inflammatory furanones |
US5045564A (en) * | 1988-12-07 | 1991-09-03 | Allergan, Inc. | Anti-inflammatory 2-furanones |
DE3906214A1 (de) * | 1989-02-28 | 1990-08-30 | Boehringer Mannheim Gmbh | Verwendung von macrolactone als antiallergica |
JP2790335B2 (ja) * | 1989-09-20 | 1998-08-27 | 株式会社クラレ | 共役γ―オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤 |
US5258400A (en) * | 1989-11-20 | 1993-11-02 | Allergan, Inc. | Anti-inflammatory furanone compounds |
US5112853A (en) * | 1989-11-20 | 1992-05-12 | Allergan, Inc. | Anti-inflammatory furanone compounds |
US5081261A (en) * | 1990-03-23 | 1992-01-14 | Allergan, Inc. | 4-(1-hydroxy-2-N-substituted sulfonamido) ethyl-5-hydroxy-2(5H)-furanones and 4-(N-substituted sulfonamido)-2-ethenyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents |
US5013850A (en) * | 1990-03-30 | 1991-05-07 | Allergan, Inc. | 4-ethyl and 4-ethenyl-5-hydroxy-2(5H)-furanones substituted on alpha carbon of the ethyl or ethenyl side chain with a long chain alkyl group and on the beta carbon with a polar group, as anti-inflammatory agents |
US5225571A (en) * | 1991-04-30 | 1993-07-06 | Allergan, Inc. | Substituted dihydroxy-bis-[5-hydroxy-2(5H)-furanone-4-yl]-alkanes as anti-inflammatory agents |
US5183906A (en) * | 1991-04-30 | 1993-02-02 | Allergan, Inc. | 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents |
US5171864A (en) * | 1991-08-30 | 1992-12-15 | Allergan, Inc. | Di-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega alkane-dioates and N,N-bis-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents |
US5169963A (en) * | 1991-08-30 | 1992-12-08 | Allergan, Inc. | Di-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega alkanedioates and N,N-bis-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents |
US5268387A (en) * | 1992-04-24 | 1993-12-07 | Allergan, Inc. | Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss |
US5451686A (en) * | 1994-04-15 | 1995-09-19 | Allergan, Inc. | 3 and 5 alkyl and phenyl 4-(hydroxy or acyloxy)-alkyl substituted 2(5H)-furanones as anti-inflammatory agents |
JP5381942B2 (ja) | 2010-09-17 | 2014-01-08 | オムロンヘルスケア株式会社 | 電子体温計およびその製造方法 |
WO2020068642A1 (en) | 2018-09-25 | 2020-04-02 | Schlumberger Technology Corporation | Piston load ring seal configurations |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57149283A (en) * | 1981-03-09 | 1982-09-14 | Fujisawa Pharmaceut Co Ltd | Long-chain fatty acid lactol |
DE3472958D1 (en) * | 1983-08-03 | 1988-09-01 | Univ California | Synthetic analgesic and/or anti-inflammatory derivatives of manoalide |
US4616089A (en) * | 1983-08-03 | 1986-10-07 | University Of California | Synthetic anti-inflammatory derivatives of manoalide |
US4447445A (en) * | 1983-08-03 | 1984-05-08 | The Regents Of The University Of Calif. | Manoalide, an anti-inflammatory analgesic marine natural product |
US4789749A (en) * | 1984-06-18 | 1988-12-06 | The Regents Of The University Of California | Manoalide analogs |
-
1986
- 1986-06-23 ZA ZA864674A patent/ZA864674B/xx unknown
- 1986-06-23 ES ES556467A patent/ES8707946A1/es not_active Expired
- 1986-06-24 NZ NZ216647A patent/NZ216647A/xx unknown
- 1986-06-24 IL IL79212A patent/IL79212A0/xx unknown
- 1986-06-24 PH PH33941A patent/PH22938A/en unknown
- 1986-06-25 EP EP86304907A patent/EP0209274A3/en not_active Ceased
- 1986-06-26 DK DK301886A patent/DK301886A/da not_active Application Discontinuation
- 1986-06-26 PT PT82850A patent/PT82850B/pt unknown
- 1986-06-27 AU AU59343/86A patent/AU583930B2/en not_active Expired - Fee Related
- 1986-06-30 HU HU862729A patent/HUT44530A/hu unknown
- 1986-06-30 KR KR1019860005263A patent/KR870000908B1/ko not_active IP Right Cessation
- 1986-06-30 JP JP61154966A patent/JPS625976A/ja active Pending
- 1986-06-30 CN CN198686104450A patent/CN86104450A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
AU5934386A (en) | 1987-01-08 |
EP0209274A2 (en) | 1987-01-21 |
PH22938A (en) | 1989-02-03 |
EP0209274A3 (en) | 1987-07-22 |
DK301886D0 (da) | 1986-06-26 |
AU583930B2 (en) | 1989-05-11 |
PT82850A (en) | 1986-07-01 |
ZA864674B (en) | 1988-02-24 |
PT82850B (en) | 1988-05-06 |
ES8707946A1 (es) | 1987-09-01 |
CN86104450A (zh) | 1986-12-31 |
NZ216647A (en) | 1989-04-26 |
HUT44530A (en) | 1988-03-28 |
IL79212A0 (en) | 1986-09-30 |
DK301886A (da) | 1987-01-02 |
KR870001187A (ko) | 1987-03-12 |
KR870000908B1 (ko) | 1987-05-06 |
JPS625976A (ja) | 1987-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES554405A0 (es) | Un procedimiento para la preparacion de derivados de aza-indol. | |
ES553044A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina. | |
ES556467A0 (es) | Un procedimiento para la preparacion de derivados de furanona. | |
ES544644A0 (es) | Un procedimiento para la preparacion de derivados de carboxamidoadenosina. | |
ES551249A0 (es) | Un procedimiento para la preparacion de peptidilaminodioles. | |
ES555834A0 (es) | Un procedimiento para la preparacion de nuevas piranopiridinas. | |
ES552502A0 (es) | Un procedimiento para la preparacion de nuevos derivados de tiazolidina. | |
ES556550A0 (es) | Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas. | |
ES552052A0 (es) | Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida. | |
ES539281A0 (es) | Un procedimiento para la preparacion de derivados de piperidina. | |
ES556738A0 (es) | Un procedimiento para la preparacion de nuevos piridazinaminas. | |
ES556127A0 (es) | Un procedimiento para la preparacion de quinolinas 2-sustituidas. | |
ES546236A0 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
ES552189A0 (es) | Un procedimiento para la preparacion de derivados de piridimilmidazolidiona. | |
ES554983A0 (es) | Un procedimiento para la preparacion de silileteres. | |
ES552297A0 (es) | Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos. | |
ES553415A0 (es) | Un procedimiento para la preparacion de derivados de ariletanolamina. | |
ES550504A0 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
ES553874A0 (es) | Un procedimiento para la preparacion de metanosulfonatos de dioxolano. | |
ES555369A0 (es) | Un procedimiento para la preparacion de un polialquenoilisocianato. | |
ES547805A0 (es) | Un procedimiento para la preparacion de nuevos derivados de guanina. | |
ES557397A0 (es) | Un procedimiento para preparar derivados arilicos de diemanidas. | |
ES557839A0 (es) | Un procedimiento para la preparacion de derivados de piperazinilo 1-4-disustituidos. | |
ES555723A0 (es) | Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas. | |
ES552241A0 (es) | Un procedimiento para la preparacion de nuevos derivados de pirazolopiridinas. |